NNC 92-1687 is a non-peptide competitive human glucagon receptor antagonist (IC50=20 μM; Ki=9.1 μM). NNC 92-1687 can be used in the research of type 2 diabetes.
References:
[1]. Madsen P, et al. Discovery and structure− activity relationship of the first non-peptide competitive human glucagon receptor antagonists[J]. Journal of medicinal chemistry, 1998, 41(26): 5150-5157.
















